Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50.5M
-
Number of holders
-
141
-
Total 13F shares, excl. options
-
27.2M
-
Shares change
-
+1.12M
-
Total reported value, excl. options
-
$548M
-
Value change
-
+$23.7M
-
Number of buys
-
75
-
Number of sells
-
-57
-
Price
-
$20.16
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q2 2021
158 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q2 2021.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.2M shares
of 50.5M outstanding shares and own 53.78% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.27M shares), FEDERATED HERMES, INC. (3.34M shares), VANGUARD GROUP INC (2.46M shares), DIMENSIONAL FUND ADVISORS LP (1.7M shares), STATE STREET CORP (1.44M shares), GOLDMAN SACHS GROUP INC (844K shares), Invesco Ltd. (788K shares), GEODE CAPITAL MANAGEMENT, LLC (689K shares), JANUS HENDERSON GROUP PLC (555K shares), and NORTHERN TRUST CORP (434K shares).
This table shows the top 141 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.